Authors:
FATHI Z
BATTAGLINO PM
IBEN LG
LI H
BAKER E
ZHANG DL
MCGOVERN R
MAHLE CD
SUTHERLAND GR
IISMAA TP
DICKINSON KEJ
ZIMANYI IA
Citation: Z. Fathi et al., MOLECULAR CHARACTERIZATION, PHARMACOLOGICAL PROPERTIES AND CHROMOSOMAL LOCALIZATION OF THE HUMAN GALR2 GALANIN RECEPTOR, Molecular brain research, 58(1-2), 1998, pp. 156-169
Authors:
FATHI Z
CUNNINGHAM AM
IBEN LG
BATTAGLINO PB
WARD SA
NICHOL KA
PINE KA
WANG JC
GOLDSTEIN ME
IISMAA TP
ZIMANYI IA
Citation: Z. Fathi et al., CLONING, PHARMACOLOGICAL CHARACTERIZATION AND DISTRIBUTION OF A NOVELGALANIN RECEPTOR (VOL 51, PG 49, 1997), Molecular brain research, 53(1-2), 1998, pp. 348-348
Authors:
FATHI Z
CUNNINGHAM AM
IBEN LG
BATTAGLINO PB
WARD SA
NICHOL KA
PINE KA
WANG JC
GOLDSTEIN ME
IISMAA TP
ZIMANYI IA
Citation: Z. Fathi et al., CLONING, PHARMACOLOGICAL CHARACTERIZATION AND DISTRIBUTION OF A NOVELGALANIN RECEPTOR, Molecular brain research, 51(1-2), 1997, pp. 49-59
Authors:
SARBIN NS
GYLYS JA
IBEN LG
MAHLE CD
IZZARELLI DG
PARKER EM
NOONAN JW
WILLIAMS AD
SMITH DW
HAMEL E
YOCCA FD
Citation: Ns. Sarbin et al., THE RECEPTOR-BINDING AND VASCULAR IN-VITRO PHARMACOLOGICAL PROFILE OFBMS-180048, A NOVEL ANTIMIGRAINE AGENT, The FASEB journal, 9(3), 1995, pp. 347-347
Citation: Z. Fathi et al., CLONING, EXPRESSION, AND TISSUE DISTRIBUTION OF A 5TH MELANOCORTIN RECEPTOR SUBTYPE, Neurochemical research, 20(1), 1995, pp. 107-113
Authors:
PARKER EM
IZZARELLI DG
NOWAK HP
MAHLE CD
IBEN LG
WANG JC
GOLDSTEIN ME
Citation: Em. Parker et al., CLONING AND CHARACTERIZATION OF THE RAT GALR1 GALANIN RECEPTOR FROM RIN14B INSULINOMA CELLS, Molecular brain research, 34(2), 1995, pp. 179-189
Authors:
PARKER EM
GRISEL DA
IBEN LG
NOWAK HP
MAHLE CD
YOCCA FD
GAUGHAN GT
Citation: Em. Parker et al., CHARACTERIZATION OF HUMAN 5-HT1 RECEPTORS EXPRESSED IN SF9 INSECT CELLS, European journal of pharmacology. Molecular pharmacology section, 268(1), 1994, pp. 43-53
Citation: Lg. Iben et al., DIFFERENTIAL SENSITIVITY OF H-3 AGONIST BINDING TO PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS IN BOVINE BRAIN, British Journal of Pharmacology, 113(4), 1994, pp. 1400-1406
Authors:
GEISSLER MA
TORRENTE JR
EISON AS
GYLYS JA
WRIGHT RN
IBEN LG
DAVIS HH
YOCCA FD
Citation: Ma. Geissler et al., EFFECTS OF BMY-33462, A SELECTIVE AND POTENT SEROTONIN TYPE-3 RECEPTOR ANTAGONIST, ON MESOLIMBIC DOPAMINE-MEDIATED BEHAVIOR, Drug development research, 29(1), 1993, pp. 18-24